While surgical removal of endobronchial tumors is considered the gold standard treatment, up to 80% of patients present with inoperable advanced disease.1
In these patients, radiotherapy and chemotherapy are commonly given to help slow the progression of the cancer and provide palliative relief from dyspnea, obstructive pneumonia or atelectasis, cough or haemoptisis.1,2 Radiotherapy can be delivered either as external beam radiotherapy (EBRT) or as high dose rate (HDR) brachytherapy.1
HDR brachytherapy can provide quick relief of symptoms and improve survival.1 Brachytherapy precisely delivers the dose of radiation to the target tumor, sparing surrounding tissues and organs from damage. Therefore, the risk of side effects and complications from treatment is generally low.1,2 Brachytherapy treatment for endobronchial tumors is usually spread out over a few weeks, with one session of treatment (fraction) per week.2 However at each treatment session, the radiation dose can be given in just a few minutes, making treatment convenient for patients.3
HDR brachytherapy can also be used as curative treatment for patients with limited endobronchial tumors who are not suitable for surgery or EBRT.4
For general information on how HDR brachytherapy works, see the background section.
“With the advent of HDR remote afterloading and computerized treatment planning, brachytherapy [for endobronchial cancers] now has no risk of radiation exposure and can be very comfortable for the patient because of the short treatment time (within minutes).”
Sharma and Rath, 20093
and other cancers
This site complies with the HONcode standard for trustworthy health information: verify here.
Please help to improve the information we provide on this site by sharing your feedback.
We hope to provide you with further useful information in the future.